Evidence map›Paper›PMID 41872105›Full record

ArticleChinese medical journal2026

Efficacy and safety of secukinumab in patients with active psoriatic arthritis at Week 16 and up to 52 weeks: Results from a Phase III, randomized, double-blind, placebo-controlled bridging study in China.

Xiaomei Leng, Yi Liu, Lin Tang, Lingyun Sun, Jingyang Li, Jiankang Hu, Hongbin Li, Shanhui Ye, Lijun Wu, Xinwang Duan and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Xiaomei LengDepartment of Rheumatology and Immunology , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing100032 , China.
Yi LiuDepartment of Rheumatology and Immunology , West China Hospital of Sichuan University , Chengdu , Sichuan610041 , China.
Lin TangDepartment of Rheumatology and Immunology , Second Affiliated Hospital of Chongqing Medical University , Chongqing400010 , China.
Lingyun SunDepartment of Rheumatology and Immunology , Drum Tower Clinical Medical College of Nanjing Medical University , Nanjing , Jiangsu210008 , China.
Jingyang LiDepartment of Rheumatology and Immunology , Zhuzhou Center Hospital , Zhuzhou , Hunan412007 , China.
Jiankang HuDepartment of Rheumatology and Immunology , Pingxiang People's Hospital , Pingxiang , Jiangxi337099 , China.
Hongbin LiDepartment of Rheumatology and Immunology , The Affiliated Hospital of Inner Mongolia Medical University , Hohhot , Inner Mongolia010030 , China.
Shanhui YeDepartment of Rheumatology , First Affiliated Hospital of Guangzhou Medical College , Guangzhou , Guangdong510120 , China.
Lijun WuDepartment of Rheumatology and Immunology , Peoples Hospital of Xinjiang Uygur Autonomous Region , Urumqi , Xinjiang830001 , China.
Xinwang DuanDepartment of Rheumatology and Immunology , The Second Affiliated Hospital of Nanchang University , Nanchang , Jiangxi330008 , China.
Huaxiang LiuDepartment of Rheumatology , Qilu Hospital of Shandong University , Jinan , Shandong250012 , China.
Ting LiDepartment of Rheumatology , Shanghai Renji Hospital , Shanghai200000 , China.
Yongfu WangDepartment of Rheumatology and Immunology , The First Affiliated Hospital of Baotou Medical College , Inner Mongolia University of Science and Technology , Baotou , Inner Mongolia014010 , China.
Mercedes BustamanteNovartis Pharmaceuticals Corporation , East Hanover , NJ07936 , USA.
Sharonjeet KaurNovartis Pharma AG , Basel4056 , Switzerland.
Rong FuChina Novartis Institutes for Biomedical Research , Shanghai201203 , China.
Yuan TianChina Novartis Institutes for Biomedical Research , Shanghai201203 , China.
Jing YangChina Novartis Institutes for Biomedical Research , Shanghai201203 , China.
Pellet PascaleNovartis Pharmaceuticals Corporation , East Hanover , NJ07936 , USA.
Xiaofeng ZengDepartment of Rheumatology and Immunology , Peking Union Medical College Hospital , Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing100032 , China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41872105
PMCPMC13544746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.